Bifidobacterium longum BB536 and Reduced Non-HDL Cholesterol

• Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

  • 2019-02-22
  • RCT
  • Nutrition Journal 18(1)
  • • M. Ruscica
    • C. Pavanello
    • S. Gandini
    • C. Macchi
    • M. Botta
    • Daria Dall’Orto
    • M. Del Puppo
    • M. Bertolotti
    • R. Bosisio
    • Giuliana Mombelli
    • C. Sirtori
    • L. Calabresi
    • P. Magni

  • PubMed: 30795775
  • DOI: 10.1186/s12937-019-0438-2

  6 Insights on

  • Reduced Non-HDL Cholesterol

  • High evidence

  Twelve-week treatment with the nutraceutical combination, compared to placebo, significantly reduced non-HDL-C (- 24%)

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes

  Dose

  present in the combination (exact dose not stated, but part of the nutraceutical combination Lactoflorene Colesterolo®)